169 related articles for article (PubMed ID: 3497051)
1. Phagocytosis and killing of Haemophilus influenzae by alveolar macrophages: no difference between smokers and non-smokers.
Jonsson S; Musher DM; Lawrence EC
Eur J Respir Dis; 1987 May; 70(5):309-15. PubMed ID: 3497051
[TBL] [Abstract][Full Text] [Related]
2. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease.
Berenson CS; Garlipp MA; Grove LJ; Maloney J; Sethi S
J Infect Dis; 2006 Nov; 194(10):1375-84. PubMed ID: 17054066
[TBL] [Abstract][Full Text] [Related]
3. Human alveolar lining material and antibacterial defenses.
Jonsson S; Musher DM; Goree A; Lawrence EC
Am Rev Respir Dis; 1986 Jan; 133(1):136-40. PubMed ID: 3484618
[TBL] [Abstract][Full Text] [Related]
4. Bovine pulmonary alveolar macrophages: antemortem recovery and in vitro evaluation of bacterial phagocytosis and killing.
Trigo E; Liggitt HD; Breeze RG; Leid RW; Silflow RM
Am J Vet Res; 1984 Sep; 45(9):1842-7. PubMed ID: 6497143
[TBL] [Abstract][Full Text] [Related]
5. Phagocytosis and killing of common bacterial pathogens of the lung by human alveolar macrophages.
Jonsson S; Musher DM; Chapman A; Goree A; Lawrence EC
J Infect Dis; 1985 Jul; 152(1):4-13. PubMed ID: 3874252
[TBL] [Abstract][Full Text] [Related]
6. In vitro phagocytosis and killing of Corynebacterium equi by alveolar macrophages of foals.
Zink MC; Yager JA; Prescott JF; Wilkie BN
Am J Vet Res; 1985 Oct; 46(10):2171-4. PubMed ID: 4062025
[TBL] [Abstract][Full Text] [Related]
7. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages.
Musher DM; Watson DA; Nickeson D; Gyorkey F; Lahart C; Rossen RD
Am J Med Sci; 1990 Mar; 299(3):158-63. PubMed ID: 2316560
[TBL] [Abstract][Full Text] [Related]
8. Effect of in vitro inoculation of bovine respiratory syncytial virus on bovine pulmonary alveolar macrophage function.
Trigo E; Liggitt HD; Evermann JF; Breeze RG; Huston LY; Silflow R
Am J Vet Res; 1985 May; 46(5):1098-103. PubMed ID: 3890630
[TBL] [Abstract][Full Text] [Related]
9. Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers.
Harris JO; Swenson EW; Johnson JE
J Clin Invest; 1970 Nov; 49(11):2086-96. PubMed ID: 4319967
[TBL] [Abstract][Full Text] [Related]
10. A small volume technique to examine and compare alveolar macrophage phagocytosis of apoptotic cells and non typeable Haemophilus influenzae (NTHi).
Ween M; Ahern J; Carroll A; Hodge G; Pizzutto S; Jersmann H; Reynolds P; Hodge S
J Immunol Methods; 2016 Feb; 429():7-14. PubMed ID: 26678160
[TBL] [Abstract][Full Text] [Related]
11. Functional evaluation of lung macrophages from cigarette smokers and nonsmokers.
Fisher GL; McNeill KL; Finch GL; Wilson FD; Golde DW
J Reticuloendothel Soc; 1982 Oct; 32(4):311-21. PubMed ID: 7161766
[TBL] [Abstract][Full Text] [Related]
12. Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke.
MartÃ-Lliteras P; Regueiro V; Morey P; Hood DW; Saus C; Sauleda J; Agustà AG; Bengoechea JA; Garmendia J
Infect Immun; 2009 Oct; 77(10):4232-42. PubMed ID: 19620348
[TBL] [Abstract][Full Text] [Related]
13. Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.
Berenson CS; Kruzel RL; Eberhardt E; Sethi S
J Infect Dis; 2013 Dec; 208(12):2036-45. PubMed ID: 23908477
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients.
Droemann D; Goldmann T; Tiedje T; Zabel P; Dalhoff K; Schaaf B
Respir Res; 2005 Jul; 6(1):68. PubMed ID: 16004610
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of bactericidal capacity of alveolar macrophages by human alveolar lining material.
Juers JA; Rogers RM; McCurdy JB; Cook WW
J Clin Invest; 1976 Aug; 58(2):271-5. PubMed ID: 956366
[TBL] [Abstract][Full Text] [Related]
16. Extracellular killing of inhaled pneumococci in rats.
Coonrod JD; Marple S; Holmes GP; Rehm SR
J Lab Clin Med; 1987 Dec; 110(6):753-66. PubMed ID: 3681117
[TBL] [Abstract][Full Text] [Related]
17. Morphologic changes of alveolar macrophages in smoking sarcoidosis patients.
Leuenberger P; Vonmoos S; Vejdovsky R
Eur J Respir Dis Suppl; 1985; 139():72-5. PubMed ID: 2412876
[TBL] [Abstract][Full Text] [Related]
18. Deficient intracellular killing of bacteria by murine alveolar macrophages.
Nibbering PH; van den Barselaar MT; van de Gevel JS; Leijh PC; van Furth R
Am J Respir Cell Mol Biol; 1989 Nov; 1(5):417-22. PubMed ID: 2534678
[TBL] [Abstract][Full Text] [Related]
19. Assessment of bacterial exposure on phagocytic capability and surface marker expression of sputum macrophages and neutrophils in COPD patients.
Lea S; Gaskell R; Hall S; Maschera B; Hessel E; Singh D
Clin Exp Immunol; 2021 Oct; 206(1):99-109. PubMed ID: 34143447
[TBL] [Abstract][Full Text] [Related]
20. Effects of oxygen exposure on it vitro function of pulmonary alveolar macrophages.
Murphey SA; Hyams JS; Fisher AB; Root RK
J Clin Invest; 1975 Aug; 56(2):503-11. PubMed ID: 807601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
